NEO Q3'26 Earnings: EPS estimate is 0.06 USD

What happened

NeoGenomics, Inc. will announce its Q3'26 results on October 28 after the market closes, expected at 4:00 PM ET. Analysts estimate revenue of 206.70 million USD and earnings per share, which means profit per share, of 0.06 USD.

Confirmed

Global impact / market context

Earnings per share shows profit per share, so the 0.06 USD estimate matters because missing it could reduce investor confidence. Revenue of 206.70 million USD is also a key test of demand for NeoGenomics' testing services.

Analyst inference

Prior quarters show revenue and earnings per share beating estimates, which may raise expectations for Q3'26. Investors may compare the 206.70 million USD revenue estimate and 0.06 USD earnings estimate against reported results.

Analyst inference

What to watch

1. Watch whether NeoGenomics reports Q3'26 revenue and earnings per share, which means profit per share, above or below the 206.70 million USD and 0.06 USD estimates. Confirmed
2. Compare reported revenue and earnings per share with prior quarters' surprises to judge whether the company keeps beating estimates, which means actual results exceeding analyst forecasts. Proposed
3. A revenue or earnings per share miss could reduce investor confidence and pressure the stock; a beat could support it, though no market reaction is stated. Analyst inference

Evidence

• Original source link unavailable